Komori
Ono Pharmaceutical (4528) · RiskReframed

Tightening environmental regulations and the risk of hazardous substance contamination

First written in FY2020. 1 of 3 entries say "Restated". Latest entry: FY2024.

3entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020 – FY20222020: 120202021: 020212022: 120222023: 020232024: 12024
Same theme, other companies

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024ReframedAnnual report

    「In addition, we have begun considering the identification of nature-related risks and measures to address them based on the recommendations of the Taskforce on Nature-related Financial Disclosures (TNFD).」

    In addition to managing environmental regulation and contamination risks, we have begun identifying nature-related risks and considering measures to address them based on the TNFD recommendations.
  2. FY2022RestatedAnnual report

    「If the introduction of a new carbon tax and regulations on greenhouse gas emissions are strengthened as measures to combat global warming, costs may increase. In addition, if unforeseen contamination by hazardous substances or related harm were to materialize, we could face exclusions from insurance coverage, costs exceeding the amount of compensation, or legal liability.」

    The risks of higher costs from tighter carbon taxes and greenhouse gas regulations, and of costs and legal liability resulting from hazardous-substance contamination, have been reconfirmed.
  3. FY2020First statedAnnual report

    「If the introduction of a new carbon tax and regulations on greenhouse gas emissions are strengthened as measures to combat global warming, costs may increase. In addition, if unforeseen contamination by hazardous substances or related harm were to materialize, we could face exclusions from insurance coverage, costs exceeding the amount of compensation, or legal liability.」

    The risk of higher costs from tighter carbon taxes and greenhouse gas emissions regulations, and the risk of costs and legal liability resulting from hazardous-substance contamination, have been listed independently for the first time.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Ono Pharmaceutical's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Tightening environmental regulations and the risk of hazardous substance contamination | ONO PHARMACEUTICAL CO.,LTD. (4528) | Komori